Skip to content

DRMAW DERMATA THERAPEUTICS INC

Follow

*W EXP 99/99/999 (warrant or right)

6 managers (6 13F filers) reported a position in DRMAW shares at 2024-12-31, 30,453 shares in all. 2 filers opened a position and 0 filers sold out during the quarter.

Managers
6
13F filers
6
New
2
Added
0
Reduced
1
Sold out
0
Shares held by filers
30,453

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2024

Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
BOOTHBAY FUND MANAGEMENT, LLC12,000$16.2K<0.01%013F-HRTimeline
TWO SIGMA SECURITIES, LLC12,857$138<0.01%new13F-HRTimeline
UBS Group AGin group UBS Group AG4,142$46<0.01%-10013F-HRTimelineGroup
ARMISTICE CAPITAL, LLC1,354$14<0.01%new13F-HRTimeline
BANK OF AMERICA CORP /DE/in group BANK OF AMERICA CORP /DE/100$1<0.01%013F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.